SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

PMCB RSS Feed
Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, Peacefulwendy, $Pistol Pete$, thenewmixer, fraum, concordia
Search This Board: 
Last Post: 10/17/2017 2:34:49 PM - Followers: 779 - Board type: Free - Posts Today: 41

Welcome to PharmaCyte BioTech
An OTCQB Company

PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.






 


 





FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment



European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b

 Company Address
   
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com
http://pharmacyte.com/
 

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

Float:
817,204,665 a/o Aug 29, 2016


For more updated information please visit: 


http://www.otcmarkets.com/stock/PMCB/profile


Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations


Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States

 

   All News Releases: 

http://www.pharmacytebiotech.com/news/

 


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans.


http://austrianova.com/products/ 



Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President
 

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director


Carlos A. Trujillo – Chief Financial Officer and Director


Walter H. Gunzburg – Chief Scientific Officer


Dr. Matthias Lohr as Chairman of Scientific Advisory Board


Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board

 


 

 

 


***DISCLAIMER***
-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.





 
 


                                   

 
 
SureTrader
Interactive Brokers Advertisement
PMCB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Current Report Filing (8-k) 10/10/2017 08:31:01 AM
PMCB News: Notice of Effectiveness (effect) 09/29/2017 06:01:57 AM
PMCB News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 09/28/2017 04:18:18 PM
PMCB News: Securities Registration Statement (simplified Form) (s-3) 09/13/2017 09:26:54 AM
PMCB News: Quarterly Report (10-q) 09/13/2017 06:06:08 AM
PostSubject
#76480  Sticky Note $PMCB Dr. Manuel Hidalgo, a member of PharmaCyte’s $Pistol Pete$ 10/16/17 01:16:38 PM
#62231  Sticky Note in full/ #2/ 01-28-2017/ Keeping an Eye on mick 01/28/17 07:35:33 PM
#52881  Sticky Note Here is a very nice list of accomplishments... Peacefulwendy 09/28/16 11:17:44 AM
#76540   The point is Morell has done nothing. Even mind1 10/17/17 02:34:48 PM
#76539   PMCBs Waggs & Thongs have no Morals thenewmixer 10/17/17 02:33:18 PM
#76538   My feeling is waggs already knows IND will efood125 10/17/17 02:32:01 PM
#76537   So, he has done nothing. KW should have mind1 10/17/17 02:26:38 PM
#76536   Hopefully " Morrel " is preparing to tell esusun 10/17/17 02:25:39 PM
#76535   I am thinking waggs will let Morell loose efood125 10/17/17 02:23:50 PM
#76534   I've seen some positive comments about PMCB hiring mind1 10/17/17 01:43:10 PM
#76533   Hmmm, crickets. I am not letting the oldmusky 10/17/17 01:26:44 PM
#76532   Biotech don't need to hire people to tell concordia 10/17/17 01:20:34 PM
#76530   Just curious, is anyone else emailing or oldmusky 10/17/17 12:17:49 PM
#76529   I don't don't get your logic.They hiring ferenc 10/17/17 12:06:41 PM
#76528   Update on diabetes 1234jklm 10/17/17 11:44:37 AM
#76527   There is no update because the news is concordia 10/17/17 11:40:32 AM
#76526   kw gave us an update on mj, which tulla236a 10/17/17 11:32:12 AM
#76525   It must be cheap ...I am paying 5000 ferenc 10/17/17 11:21:22 AM
#76524   Must be bad intel... I see the real Onlyinvestor 10/17/17 11:18:19 AM
#76523   what heavy volume are you referring to? plusorminus 10/17/17 11:14:27 AM
#76522   Can anyone explain the heavy volume this morning...and Onlyinvestor 10/17/17 11:06:59 AM
#76521   There is NO Oct PR due. But PR Intotheblack 10/17/17 10:58:47 AM
#76520   Okay - shouldn't have called it 'headquarters' and Stks_Not_Toys 10/17/17 10:57:16 AM
#76519   News. Cellular activation for cabbinoids 1234jklm 10/17/17 10:56:37 AM
#76518   PlanB? China is no longer anyone's plan B. 1234jklm 10/17/17 10:54:14 AM
#76517   LOL its shared office space not a headquarters concordia 10/17/17 10:53:08 AM
#76516   My point is hopefully he can bring investors hockeypond 10/17/17 10:50:47 AM
#76515   In looking at the latest 8-k filing I Stks_Not_Toys 10/17/17 10:42:57 AM
#76514   This means no update today. 10 business days Mens et Manus 10/17/17 09:56:23 AM
#76513   I still believe we'll soon get news of PINKribbon 10/17/17 09:48:25 AM
#76512   $PMCB PharmaCyte Biotech Research Identifies Enzyme Acti $Pistol Pete$ 10/17/17 09:31:41 AM
#76511   Wow, thank you, very interesting. oldmusky 10/17/17 09:29:29 AM
#76510   No I am saying this treatment is silly. concordia 10/17/17 09:22:00 AM
#76509   Hey Musky guess what... GodisGreat 10/17/17 09:10:51 AM
#76508   Hey Musky guess what... GodisGreat 10/17/17 09:10:50 AM
#76507   Hey Musky guess what... GodisGreat 10/17/17 09:10:31 AM
#76506   Hey Musky guess what... GodisGreat 10/17/17 09:10:13 AM
#76505   Are you saying that cell encapsulation is "silly?" anarmyofme 10/17/17 09:01:05 AM
#76504   I just thought this was interesting. Janssen oldmusky 10/17/17 08:16:00 AM
#76503   Dr Thong go PMCB thenewmixer 10/17/17 06:17:57 AM
#76502   What about dr tongs connection with CITIC? 1234jklm 10/17/17 02:39:10 AM
#76501   $PMCB https://buckeyebusinessreview.com/2017/10/16/is-pharmacyte-biotech-inc-pmc $Pistol Pete$ 10/17/17 12:58:50 AM
#76499   OK. Please keep your PLANNED UPDATE. Whatever. When rcstock 10/16/17 10:23:26 PM
#76498   RC in the response I got back from A2Z 10/16/17 09:15:47 PM
#76497   Watch the series of videos on YouTube and concordia 10/16/17 08:50:43 PM
#76496   Plowshare...and what about the timing of that agreement efood125 10/16/17 07:49:06 PM
#76495   I suppose you are in the camp that efood125 10/16/17 07:34:40 PM
#76494   Can't wait to hear the spin....Pete? SMEG 10/16/17 06:27:20 PM
#76493   PMCB Dr. Manuel Hidalgo never mention cell in thenewmixer 10/16/17 04:07:57 PM
#76492   good one Yuen and Tong ( Cheech and thenewmixer 10/16/17 04:05:43 PM
#76491   RC-----Amen! Pmcbinv 10/16/17 03:36:06 PM
#76489   exactly . esusun 10/16/17 03:27:57 PM
#76488   Stem cells, China, Jansen, all speculation++++ rcstock 10/16/17 02:44:35 PM
PostSubject